Proposal to list medical devices supplied by Karl Storz Endoscopy New Zealand Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Karl Storz Endoscopy New Zealand Limited (“Karl Storz”) in Part III of Section H of the Pharmaceutical Schedule from 1 November 2021.
We propose to list medical devices supplied in the following categories:
Consultation closes at 4pm Wednesday 8 September 2021 and feedback can be emailed to email@example.com.
What would the effect be?
From 1 November 2021, Karl Storz’s range of medical devices in the categories noted above would be listed under a national agreement for all DHBs to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply, with DHBs continuing to be able to purchase other suppliers’ brands of endomechanical & electrosurgical products, and obstetrics and gynaecology equipment and products.
The Agreement would supersede any existing DHB contracts with this supplier for the medical devices listed in Schedule 1 in the Agreement. Any device listed in the PHARMAC Agreement and purchased by a DHB would be at the price, terms and conditions stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.
As part of the Agreement, Karl Storz would provide appropriate training and education services that would be tailored to the needs of the individuals DHBs, in formats and at times as required by DHBs.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Suppliers and wholesalers
- DHB staff:
- Perioperative staff
- Theatre staff
- Surgical and general ward staff
- Delivery suite staff
- Obstetricians and Gynaecologists
- Clinical engineers
- Sterile services personnel
- Procurement and supply chain personnel
About the medical devices
Endomechanical and electrosurgical products
Endomechanical and Electrosurgical Products are used in a vast range of surgical specialties and procedures. Many have been specifically designed to be used for minimally invasive surgical techniques whilst others are only used in open surgery procedures. Some require power sources or other equipment to perform their function.
The Endomechanical and Electrosurgical Products category encompasses the product ranges of endomechanical instruments, electrosurgical instruments, energy platforms and their associated consumable products. This covers both disposable and re-usable options, as well as the portable power sources or other equipment that specific instruments may require to be functional.
Obstetrics and gynaecology equipment and products
This category includes all equipment and consumables used in the obstetrics and gynaecology equipment and products specialities. Products used in delivery suites and by midwives on the wards are included. Gynaecology is the specialty that treats conditions related to female reproductive organs. A small number of devices related to fertility and sterility may be listed as some limited assisted reproduction services are provided by a small number of DHB Hospitals. However, most funded services are provided by private clinics are therefore out of scope for Pharmac.
Why we’re proposing this
In 2018 PHARMAC issued request for proposals (RFPs) for:
- supply of endomechanical instruments, electrosurgical instruments, energy platforms and consumables.
- supply of obstetrics and gynaecology equipment and products.
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers to seek provisional agreements and this is the latest proposal to arise from those processes. We intend to consult on further provisional agreements with other suppliers in each of the categories over the coming months.
Details about our proposal
The proposal would result in the listing of medical devices in the following brands and quantities:
Endomechanical and electrosurgical
Obstetrics and gynaecology
Further information, including pricing and contractual details, has been provided to DHB Procurement personnel. Clinicians interested in further detail on what this change means for their DHB should engage with their Procurement teams.
To provide feedback
Send us an email: firstname.lastname@example.org by 4pm Wednesday 8 September 2021.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.